Drug Profile
Ganaplacide - Novartis
Alternative Names: Ganaplacide; GNF-156; KAF-156Latest Information Update: 16 Feb 2024
Price :
$50
*
At a glance
- Originator Novartis
- Class 2 ring heterocyclic compounds; Amines; Aniline compounds; Antimalarials; Antiprotozoals; Fluorobenzenes; Imidazoles; Ketones; Piperazines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Falciparum malaria; Malaria; Vivax malaria